Kenai Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- February 29, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $82,000,000
Company Info
- Founders
- Dr. Howard Federoff
- Company Description
- Kenai Therapeutics focuses on developing therapies for neurodegenerative movement disorders.
- Market
- Neurological disorders
- Location
- San Diego, CA, USA
- Coinvestors
- Alaska Permanent Fund, Cure Ventures, Euclidean Capital, Saisei Ventures, The Column Group